Deal bolsters medtech firm’s advance into USA market

Medical technology business, Surgical Innovations Group (SI), has struck a USA distribution deal with Microline Surgical Inc for its YelloPort+Plus and YelloPort Elite access devices.

SI, which is based in Leeds, says the five-year agreement gives it a “significant opportunity” for growth in the US market for Trocars – a type of surgical instrument. 

It adds that Microline’s sales and marketing structure is ideally placed to leverage its experience with resposable surgical instruments to effectively drive sales in the US.

Based near Boston, Microline designs, makes and distributes instruments aimed at the minimally invasive surgical instrument (MIS) market. 

Its portfolio of products is complementary to those offered by SI, with a focus on the resposable ethos of cost and sustainability.

Timothy Gehlmann, president and CEO of Microline, said: “Microline is excited to add the YelloPort line of trocars from SI to our product portfolio. 

“The SI trocar line complements our MIS instrument line by broadening our solution offering to customers.”

Adam Power, group development director at SI, added: “The United States accounts for almost half of the worldwide trocar market.

“Microline has a direct sales team with considerable experience in the selling of Resposable surgical devices.

“Microline and Surgical Innovations, through its UK subsidiary Elemental Healthcare, share a long history of synergy and growth and we are very excited to replicate this successful relationship in the United States.”